This lead to the identification of “masked” or “hidden” cases of BCR/ABL1 translocation (5–8), and to the understanding that “CML-like” changes can be found without the diagnostic hallmark of CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.